Hirsch, Vera Kinnear, Calum Rodriguez-Lorenzo, Laura Monnier, Christophe A. Rothen-Rutishauser, Barbara Balog, Sandor Petri-Fink, Alke 2014-04-21 Agglomeration of nanoparticles in biological fluids is a pervasive phenomenon that leads to difficulty in the interpretation of results from in vitro exposures, primarily due to the differing particokinetics of agglomerates to nanoparticles. Therefore, well-defined small agglomerates were designed that possessed different particokinetics profiles, and their cellular uptake was compared to a computational model of dosimetry. The approach used here paves the way for a better understanding of the impact of agglomeration on the nanoparticle-cell interaction. application/pdf https://folia.unifr.ch/global/documents/303512 https://folia.unifr.ch/documents/303512/files/fin_vda.pdf https://folia.unifr.ch/documents/303512/files/fin_vda_sm.pdf eng info:eu-repo/semantics/altIdentifier/doi/10.1039/C4NR00460D info:eu-repo/semantics/openAccess License undefined Nanoscale. - 2014, vol. 6, no. 13, p. 7325-7331 info:eu-repo/classification/udc/54 In Vitro dosimetry of agglomerates http://purl.org/coar/resource_type/c_6501